Your browser doesn't support javascript.
loading
Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience.
Westafer, Lauren M; Beck, Samantha A; Simon, Caty; Potee, Benjamin; Soares, William E; Schoenfeld, Elizabeth M.
Affiliation
  • Westafer LM; Department of Emergency Medicine, University of Massachusetts Chan Medical School-Baystate, Springfield, MA; Department for Healthcare Delivery and Population Science, University of Massachusetts Chan Medical School-Baystate, Springfield, MA. Electronic address: Lauren.Westafer@baystatehealth.org.
  • Beck SA; UMass Chan Medical School, Worcester, MA.
  • Simon C; National Survivors Union, Greensboro, NC; Whose Corner Is It Anyway, Holyoke, MA.
  • Potee B; UMass Chan Medical School, Worcester, MA.
  • Soares WE; Department of Emergency Medicine, University of Massachusetts Chan Medical School-Baystate, Springfield, MA; Department for Healthcare Delivery and Population Science, University of Massachusetts Chan Medical School-Baystate, Springfield, MA.
  • Schoenfeld EM; Department of Emergency Medicine, University of Massachusetts Chan Medical School-Baystate, Springfield, MA; Department for Healthcare Delivery and Population Science, University of Massachusetts Chan Medical School-Baystate, Springfield, MA.
Ann Emerg Med ; 83(4): 340-350, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38180403
ABSTRACT
STUDY

OBJECTIVE:

Although an increasing number of emergency departments (ED) offer opioid agonist treatment, naloxone, and other harm reduction measures, little is known about patient perspectives on harm reduction practices delivered in the ED. The objective of this study was to identify patient-focused barriers and facilitators to harm reduction strategies in the ED.

METHODS:

We conducted semistructured interviews with a convenience sample of individuals in Massachusetts diagnosed with opioid use disorder. We developed an interview guide, and interviews were recorded, transcribed, and analyzed in an iterative process using reflexive thematic analysis. After initial interviews and coding, we triangulated the results among a focus group of 4 individuals with lived experience.

RESULTS:

We interviewed 25 participants with opioid use disorder, 6 recruited from 1 ED and 19 recruited from opioid agonist treatment clinics. Key themes included accessibility of harm reduction supplies, lack of self-care resulting from withdrawal and hopelessness, the impact of stigma on the likelihood of using harm reduction practices, habit and knowledge, as well as the need for user-centered harm reduction interventions.

CONCLUSION:

In this study, people with lived experience discussed the characteristics and need for user-centered harm reduction strategies in the ED that centered on reducing stigma, treatment of withdrawal, and availability of harm reduction materials.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Harm Reduction / Opioid-Related Disorders Type of study: Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: Ann Emerg Med Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Harm Reduction / Opioid-Related Disorders Type of study: Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: Ann Emerg Med Year: 2024 Type: Article